AEMD Projected Dividend Yield
Com Par $0.001(New)/Aethlon Medical Inc ( NASDAQ : AEMD )Aethlon Medical, Inc. is a medical therapeutic company which develop the Hemopurifier, an immunotherapeutic device aimed at treating cancer, life-threatening viral infections, and aiding in organ transplantation. Pre-clinical studies show it can remove harmful exosomes from biological fluids using lectin-based technology. The FDA has designated it as a Breakthrough Device for advanced or metastatic cancer unresponsive to standard therapies and for treating life-threatening viruses not addressed by approved therapies, with an open Investigational Device Exemption. 21 YEAR PERFORMANCE RESULTS |
AEMD Dividend History Detail AEMD Dividend News AEMD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |